Perrigo Price to Book Ratio 2012-2025 | PRGO
Historical price to book ratio values for Perrigo (PRGO) over the last 10 years. The current price to book ratio for Perrigo as of January 16, 2026 is 0.47.
| Perrigo Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-16 | 15.03 | 0.47 | |
| 2025-09-30 | 21.79 | $32.31 | 0.67 |
| 2025-06-30 | 25.82 | $32.50 | 0.79 |
| 2025-03-31 | 26.81 | $31.81 | 0.84 |
| 2024-12-31 | 24.33 | $31.64 | 0.77 |
| 2024-09-30 | 24.59 | $33.45 | 0.74 |
| 2024-06-30 | 23.84 | $33.32 | 0.72 |
| 2024-03-31 | 29.59 | $34.39 | 0.86 |
| 2023-12-31 | 29.29 | $35.19 | 0.83 |
| 2023-09-30 | 28.82 | $34.97 | 0.82 |
| 2023-06-30 | 30.39 | $35.81 | 0.85 |
| 2023-03-31 | 31.83 | $35.73 | 0.89 |
| 2022-12-31 | 30.03 | $35.95 | 0.84 |
| 2022-09-30 | 31.16 | $34.20 | 0.91 |
| 2022-06-30 | 35.20 | $36.03 | 0.98 |
| 2022-03-31 | 33.13 | $37.92 | 0.87 |
| 2021-12-31 | 33.29 | $38.50 | 0.86 |
| 2021-09-30 | 40.23 | $38.76 | 1.04 |
| 2021-06-30 | 38.74 | $41.25 | 0.94 |
| 2021-03-31 | 34.02 | $41.63 | 0.82 |
| 2020-12-31 | 37.38 | $42.49 | 0.88 |
| 2020-09-30 | 38.19 | $42.64 | 0.90 |
| 2020-06-30 | 45.78 | $43.30 | 1.06 |
| 2020-03-31 | 39.67 | $42.46 | 0.93 |
| 2019-12-31 | 42.46 | $42.65 | 1.00 |
| 2019-09-30 | 45.75 | $42.32 | 1.08 |
| 2019-06-30 | 38.80 | $42.11 | 0.92 |
| 2019-03-31 | 39.06 | $41.92 | 0.93 |
| 2018-12-31 | 31.30 | $41.71 | 0.75 |
| 2018-09-30 | 57.02 | $41.65 | 1.37 |
| 2018-06-30 | 58.57 | $42.86 | 1.37 |
| 2018-03-31 | 66.78 | $44.42 | 1.50 |
| 2017-12-31 | 69.68 | $43.83 | 1.59 |
| 2017-09-30 | 67.55 | $42.91 | 1.57 |
| 2017-06-30 | 60.14 | $42.65 | 1.41 |
| 2017-03-31 | 52.76 | $42.31 | 1.25 |
| 2016-12-31 | 66.00 | $41.55 | 1.59 |
| 2016-09-30 | 73.09 | $52.18 | 1.40 |
| 2016-06-30 | 71.66 | $63.19 | 1.13 |
| 2016-03-31 | 100.96 | $67.91 | 1.49 |
| 2015-12-31 | 114.07 | $70.63 | 1.62 |
| 2015-09-30 | 123.87 | $73.31 | 1.69 |
| 2015-06-30 | 145.47 | 0.00 | |
| 2015-03-31 | 130.22 | $68.08 | 1.91 |
| 2014-12-31 | 131.38 | $69.00 | 1.90 |
| 2014-09-30 | 117.96 | $65.10 | 1.81 |
| 2014-06-30 | 114.40 | 0.00 | |
| 2014-03-31 | 121.29 | $63.97 | 1.90 |
| 2013-12-31 | 120.27 | $63.56 | 1.89 |
| 2013-09-30 | 96.63 | $26.19 | 3.69 |
| 2013-06-30 | 94.70 | 0.00 | |
| 2013-03-31 | 92.86 | $23.67 | 3.92 |
| 2012-12-31 | 81.29 | $22.44 | 3.62 |
| 2012-09-30 | 90.70 | $20.95 | 4.33 |
| 2012-06-30 | 92.00 | 0.00 | |
| 2012-03-31 | 80.54 | $18.98 | 4.24 |
| 2011-12-31 | 75.79 | $17.48 | 4.34 |
| 2011-09-30 | 75.57 | $16.57 | 4.56 |
| 2011-06-30 | 68.33 | 0.00 | |
| 2011-03-31 | 61.79 | $15.38 | 4.02 |
| 2010-12-31 | 49.16 | $14.17 | 3.47 |
| 2010-09-30 | 49.80 | $13.07 | 3.81 |
| 2010-06-30 | 45.75 | 0.00 | |
| 2010-03-31 | 45.43 | $11.57 | 3.93 |
| 2009-12-31 | 30.78 | $10.85 | 2.84 |
| 2009-09-30 | 26.22 | $10.50 | 2.50 |
| 2009-06-30 | 21.39 | 0.00 | |
| 2009-03-31 | 19.08 | $9.13 | 2.09 |
| 2008-12-31 | 24.76 | $8.97 | 2.76 |
| 2008-09-30 | 29.43 | $9.56 | 3.08 |
| 2008-06-30 | 24.27 | 0.00 | |
| 2008-03-31 | 28.78 | $9.22 | 3.12 |
| 2007-12-31 | 26.67 | $8.75 | 3.05 |
| 2007-09-30 | 16.24 | $8.24 | 1.97 |
| 2007-06-30 | 14.86 | 0.00 | |
| 2007-03-31 | 13.37 | $7.62 | 1.75 |
| 2006-12-31 | 13.07 | $7.47 | 1.75 |
| 2006-09-30 | 12.78 | $7.15 | 1.79 |
| 2006-06-30 | 12.10 | 0.00 | |
| 2006-03-31 | 12.22 | $6.71 | 1.82 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.068B | $4.373B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $211.725B | 24.40 |
| EssilorLuxottica (ESLOY) | France | $146.103B | 0.00 |
| Stryker (SYK) | United States | $139.118B | 27.62 |
| Boston Scientific (BSX) | United States | $130.559B | 29.85 |
| Medtronic (MDT) | Ireland | $124.048B | 17.19 |
| Medline (MDLN) | United States | $57.961B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.907B | 0.00 |
| Agilent Technologies (A) | United States | $39.588B | 25.03 |
| ResMed (RMD) | United States | $37.591B | 26.02 |
| GE HealthCare Technologies (GEHC) | United States | $37.239B | 17.81 |
| Koninklijke Philips (PHG) | Netherlands | $28.483B | 18.60 |
| Terumo (TRUMY) | Japan | $20.476B | 23.05 |
| Insulet (PODD) | United States | $20.239B | 62.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.303B | 10.79 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.893B | 0.00 |
| Baxter (BAX) | United States | $10.338B | 8.34 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.457B | 30.41 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.261B | 12.98 |
| Envista Holdings (NVST) | United States | $4.150B | 23.81 |
| BillionToOne (BLLN) | United States | $4.061B | 0.00 |
| ICU Medical (ICUI) | United States | $3.855B | 24.48 |
| Haemonetics (HAE) | United States | $3.378B | 15.04 |
| Prestige Consumer Healthcare (PBH) | United States | $3.131B | 14.28 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.255B | 14.50 |
| Neogen (NEOG) | United States | $2.012B | 44.05 |
| LeMaitre Vascular (LMAT) | United States | $2.002B | 40.31 |
| AtriCure (ATRC) | United States | $1.942B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.805B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.678B | 73.55 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.471B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.437B | 20.80 |
| Kestra Medical Technologies (KMTS) | United States | $1.333B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.176B | 348.86 |
| Capricor Therapeutics (CAPR) | United States | $1.113B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.062B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.002B | 0.00 |
| InMode (INMD) | Israel | $0.881B | 9.96 |
| Valneva SE (VALN) | France | $0.867B | 0.00 |
| Omeros (OMER) | United States | $0.852B | 0.00 |
| CeriBell (CBLL) | United States | $0.814B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.578B | 15.67 |
| Cerus (CERS) | United States | $0.499B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.479B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Brainsway (BWAY) | Israel | $0.454B | 77.27 |
| Canopy Growth (CGC) | Canada | $0.438B | 0.00 |
| Quanterix (QTRX) | United States | $0.346B | 0.00 |
| Evolus (EOLS) | United States | $0.337B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 22.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.276B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.00 |
| TerrAscend (TSNDF) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Organigram Global (OGI) | Canada | $0.218B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.203B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.27 |
| Accendra Health (ACH) | United States | $0.195B | 1.95 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.192B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.146B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.79 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| MacroGenics (MGNX) | United States | $0.109B | 0.00 |
| Exagen (XGN) | United States | $0.106B | 0.00 |
| Biote (BTMD) | United States | $0.106B | 4.64 |
| Sharps Technology (STSS) | United States | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 24.46 |
| Nephros (NEPH) | United States | $0.048B | 34.46 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Veru (VERU) | United States | $0.043B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.031B | 15.67 |
| Jin Medical (ZJYL) | China | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.018B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |